Fulvestrant for the Treatment of Pulmonary Arterial Hypertension

Ann Am Thorac Soc. 2019 Nov;16(11):1456-1459. doi: 10.1513/AnnalsATS.201904-328RL.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Estrogen Receptor Antagonists / administration & dosage*
  • Estrogen Receptor Antagonists / adverse effects
  • Female
  • Fulvestrant / administration & dosage*
  • Fulvestrant / adverse effects
  • Humans
  • Injections, Intramuscular
  • Middle Aged
  • Pilot Projects
  • Postmenopause
  • Proof of Concept Study
  • Pulmonary Arterial Hypertension / drug therapy*
  • Pulmonary Arterial Hypertension / physiopathology
  • Treatment Outcome

Substances

  • Estrogen Receptor Antagonists
  • Fulvestrant